These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6303530)

  • 21. Release and specific binding of prostaglandins in bovine pineal gland.
    Cardinali DP; Ritta MN; Speziale NS; Gimeno MF
    Prostaglandins; 1979 Oct; 18(4):577-89. PubMed ID: 531226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in prostaglandin E2, prostaglandin F2 alpha and prostacyclin contents and their response to thyrotrophin stimulation and in prostaglandin-stimulated cyclic AMP response in normal and Grave's thyroid slices.
    Takasu N; Takahashi K; Ishigami T; Yamada T; Sato S
    J Endocrinol; 1983 Sep; 98(3):357-63. PubMed ID: 6311931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of prostaglandin-receptors in human and rat liver: interspecies differences at the prostaglandin receptor-level.
    Virgolini I; Müller C; Hermann M; Schütz W; Sinzinger H
    Prostaglandins; 1988 Dec; 36(6):807-18. PubMed ID: 2469102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rat osteogenic sarcoma cells:effects of some prostaglandins, their metabolites and analogues on cyclic AMP production.
    Atkins D; Martin TJ
    Prostaglandins; 1977 May; 13(5):861-71. PubMed ID: 194286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of prostaglandin synthetase inhibitors on prostaglandin E2 binding and on prostaglandin- or cholera toxin-induced cyclic AMP accumulation in the rabbit uterus.
    Zor U; Koch R; Naor Z
    Adv Prostaglandin Thromboxane Res; 1976; 1():331-5. PubMed ID: 187046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostaglandin E2 receptor binding and action in human fat cells.
    Richelsen B; Eriksen EF; Beck-Nielsen H; Pedersen O
    J Clin Endocrinol Metab; 1984 Jul; 59(1):7-12. PubMed ID: 6144693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modified LDL decreases the binding of prostaglandin E2, I2, and E1 onto monocytes in patients with peripheral vascular disease.
    Li SR; Yang Q; Koller E; Kurtaran A; Bischof C; Leimer M; Rauscha F; Pidlich J; Virgolini I
    Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2066-73. PubMed ID: 9351373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostaglandin E-binding sites in the fetal adrenal.
    Karaplis AC; Powell WS
    Endocrinology; 1981 Dec; 109(6):2124-8. PubMed ID: 6118260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enrichment and characterization of specific [3H]PGE2 binding sites in the porcine gastric mucosa.
    Beinborn M; Netz S; Staar U; Sewing KF
    Eur J Pharmacol; 1988 Mar; 147(2):217-26. PubMed ID: 2452750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostaglandin F2 alpha antagonizes thromboxane A2-induced human platelet aggregation.
    Hung SC; Ghali NI; Venton DL; Le Breton GC
    Prostaglandins; 1982 Aug; 24(2):195-206. PubMed ID: 6293001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical pathways involved in the translation of physical stimulus into biological message.
    Binderman I; Shimshoni Z; Somjen D
    Calcif Tissue Int; 1984; 36 Suppl 1():S82-5. PubMed ID: 6331615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostaglandin E2 causes a transient inhibition of mineral mobilization, matrix degradation, and lysosomal enzyme release from mouse calvarial bones in vitro.
    Lerner UH; Ransjö M; Ljunggren O
    Calcif Tissue Int; 1987 Jun; 40(6):323-31. PubMed ID: 2440532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of specific prostaglandin E receptor in isolated rat Leydig cells.
    Seböková E; Kolena J
    Endocrinol Exp; 1978 Sep; 12(3):147-56. PubMed ID: 213258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Noradrenaline and prostaglandin E2 stimulate LH-RH release from rat median eminence through distinct 1-alpha-adrenergic and PGE2 receptors.
    Heaulme M; Dray F
    Neuroendocrinology; 1984 Nov; 39(5):403-7. PubMed ID: 6096749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterogeneity of prostaglandin E2 binding in murine mammary tumor cells differing in metastatic potential.
    Fulton AM; Hanchin CM; Butler WB
    Invasion Metastasis; 1988; 8(1):17-30. PubMed ID: 3422634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in responsiveness of rat granulosa cells to prostaglandin E2 and follicle-stimulating hormone during culture.
    Goff AK; Armstrong DT
    Can J Physiol Pharmacol; 1983 Jun; 61(6):608-13. PubMed ID: 6309352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostaglandin E2 synthesis in the inner medullary collecting duct of the rat: implications for vasopressin-dependent cyclic AMP formation.
    Jackson BA
    J Cell Physiol; 1986 Oct; 129(1):60-4. PubMed ID: 3020064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of cyclic AMP formation and progesterone secretion by human chorionic gonadotropin, epinephrine, buserelin and prostaglandins in normal or human chorionic gonadotropin desensitized rat immature luteal cells in monolayer culture.
    Massicotte J; Lachance R; Labrie F
    J Steroid Biochem; 1984 Dec; 21(6):745-54. PubMed ID: 6098787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostaglandin moieties that determine receptor binding specificity in the bovine corpus luteum.
    Anderson LE; Schultz MK; Wiltbank MC
    J Reprod Fertil; 1999 May; 116(1):133-41. PubMed ID: 10505064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostaglandin E2 inhibits secretagogue-induced enzyme secretion from rat pancreatic acini.
    Mössner J; Secknus R; Spiekermann GM; Sommer C; Biernat M; Bahnsen H; Fischbach W
    Am J Physiol; 1991 May; 260(5 Pt 1):G711-9. PubMed ID: 1709788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.